Related Experiment Video
Updated: Jun 16, 2026
09:17
Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
21.6K
Macular Neural and Microvascular Alterations in Type 2 Diabetes Without Retinopathy: A SS-OCT Study
Yining Dai1, Dongping Zheng1, Juwei Zhao1
1Shanxi Eye Hospital Affiliated to Shanxi Medical University (Y.D., D.Z., J.Z., K.W., G.Z.), Taiyuan, Shanxi, China.
American Journal of Ophthalmology
|March 1, 2024
Summary
Early detection of diabetic retinal disease is possible in Type 2 Diabetes Mellitus (T2DM) patients without retinopathy. Swept-source optical coherence tomography (SS-OCT) identified reduced macular retinal nerve fiber layer (RNFL) and ganglion cell-inner plexiform layer (GC-IPL) thickness.
Area of Science:
- Ophthalmology
- Diabetology
- Medical Imaging
Background:
- Type 2 Diabetes Mellitus (T2DM) poses a significant risk for diabetic retinopathy.
- Early detection of microvascular and neural alterations is crucial for managing T2DM complications.
- Non-invasive imaging techniques are vital for identifying subclinical retinal changes.
Purpose of the Study:
- To identify specific markers of macular neural and microvascular alterations in T2DM patients without clinically observable retinopathy.
- To compare these alterations with age-matched controls using advanced imaging technology.
Main Methods:
- A prospective cross-sectional study involving 49 T2DM patients and 51 controls.
- Swept-source optical coherence tomography (SS-OCT) angiography was performed on all participants.
- Quantitative analysis included measuring retinal layer thickness and macular vascular indices.
Main Results:
- T2DM patients showed significantly reduced macular thickness in the ganglion cell-inner plexiform layer (GC-IPL) and retinal nerve fiber layer (RNFL).
- Macular full retinal thickness was also significantly lower in T2DM patients.
- Subtle but significant changes in macular vascular skeleton density were observed in T2DM patients.
Conclusions:
- Macular RNFL and GC-IPL thickness measurements using SS-OCT are superior indicators for early detection of diabetic retinal disease in T2DM.
- These findings highlight the potential for SS-OCT in identifying individuals at risk before clinical retinopathy is apparent.
- Further research is needed to explore the full clinical implications of these early subclinical changes.
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:27Diabetic Retinopathy
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...